Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
LONDON, ONTARIO, Nov. 10, 2020 (GLOBE NEWSWIRE) -- Too many children around the world go day to day without enough food, water, shelter and protection. COVID-19 has made this reality even worse....
-
Portland, OR, Nov. 10, 2020 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global medical imaging reagents industry generated $11.69 billion in 2019, and is...
-
Chicago, Nov. 10, 2020 (GLOBE NEWSWIRE) -- The Healthcare Financial Management Association (HFMA) today announced that, following rigorous review, Simon’s Agency, Inc. has once again achieved the...
-
Atlanta, GA, Nov. 10, 2020 (GLOBE NEWSWIRE) -- Essential Spice launched its eCommerce platform today becoming one of the first food companies in the country to cut out the middleman and provide...
-
SEATTLE, Nov. 10, 2020 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company seeking to discover and develop innovative medicines in areas of...
-
ROCKVILLE, Md., Nov. 10, 2020 (GLOBE NEWSWIRE) -- American Gene Technologies (AGT) announced today that the first trial participant was enrolled in the Phase 1 trial of AGT103-T, a new cell and gene...
-
WAYNE, N.J. and BE’ER SHEVA, Israel, Nov. 10, 2020 (GLOBE NEWSWIRE) -- Konica Minolta Healthcare Americas, Inc., and DiA Imaging Analysis Ltd. jointly announce the expanded deployment of the LVivo...
-
Portland, OR, Nov. 10, 2020 (GLOBE NEWSWIRE) -- As per the report, the global hydrocephalus shunts market was pegged at $291.0 million in 2019, and is projected to reach $322.01 million by 2027,...
-
OXFORD, United Kingdom and MARLBOROUGH, Mass., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq: OXFD) (the “Company”), a global, high-growth diagnostics company, today...
-
CRANBURY, N.J., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Rafael Pharmaceuticals, Inc. (“Rafael” or the “Company”), a leader in the growing field of cancer metabolism-based therapeutics, announced today...